SCN4A and hypokalemic periodic paralysis: It would be very interesting to test 1-(2,4-xylyl) guanidine carbonate in the two transgenic animal models of HypoPP (Wu et al., 2011, 2012) in which the phenotype is caused by a Nav1.4 mutation in one model and a Cav1.1 mutation in the other.